[-] Show simple item record

Do patients at high risk of Alzheimer's disease benefit from early treatment?

URI
http://hdl.handle.net/10355/3873
dc.contributor.authorHolt, Jameseng
dc.contributor.authorStiltner, Lynettaeng
dc.contributor.authorWallace, Rickeng
dc.date.issued2009eng
dc.description.abstractTreating patients with early-stage Alzheimer's disease yields statistically significant, though perhaps not clinically significant, improvement in cognition and global function (strength of recommendation [SOR]: A, consistent evidence from multiple randomized controlled trials [RCTs]). In a few cases, it may delay loss of function and need for long-term care.eng
dc.identifier.urihttp://hdl.handle.net/10355/3873eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 58, no. 06 (June 2009): 320-322.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectnonpharmacologic treatmentseng
dc.subjectdementiaeng
dc.subjectdisease preventioneng
dc.subject.lcshAlzheimer's disease -- Treatmenteng
dc.subject.lcshAlzheimer's disease -- Age factorseng
dc.subject.lcshCholinesterase inhibitors -- Effectivenesseng
dc.subject.lcshCognition disorders -- Treatmenteng
dc.titleDo patients at high risk of Alzheimer's disease benefit from early treatment?eng
dc.typeArticleeng


Files in this item

[PDF]
Name:
DoPatientsHighRiskAlzheimers.pdf
Size:
2.034Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

[-] Show simple item record